A Quarter Of Chinese At Risk Of CVD, With 2006-2015 Costs Estimated At $558 Billion
This article was originally published in PharmAsia News
Executive Summary
At a recent World Congress of Cardiology gathering in Beijing, leading experts underscored the severity of China's cardiovascular disease (CVD) situation, and promoted the preventative use of aspirin to control risk factors